Hints and tips:
...He has donated more than $600mn to Chicago organisations, even funding the reconstruction of the city’s pedestrian and cycling path along Lake Michigan....
...Styled after US reconstruction efforts in postwar Europe, the plan would have entailed selling nuclear reactors to Saudi Arabia — potentially handing Barrack a financial windfall....
...European campaigns by US activists have deployed $9.9bn this year, compared with only $2bn last year....
...books roughly 10 times their shareholder equity, but the loan portfolios at MDBs are half of that or even less — about four times equity for the World Bank, and only twice equity for the European Bank for Reconstruction...
...In part, he says, this reflects regulatory changes that increase the upfront payments the asset reconstruction companies must make when buying assets....
...“It is not necessary in reconstruction [equipment] to be big to be successful,” he said, after announcing full-year results that were dented by adverse currency movements and a legal settlement but otherwise...
...and Biomet....
...“The margin will be lower because of three factors: additional investment in R&D, the dilution from our Healthpoint acquisition, and the US medical device tax, which will cost us about $25m [in 2013],” said...
...Japan’s Q1 GDP growth was higher than expected at an annualised rate of 4.1%, but the figure was boosted by reconstruction spending that’s poised to fade just as a worsening in Europe’s crisis threatens...
...Here we go again… Friday’s Daily Telegraph: US orthopaedics giant Biomet is set to begin informal talks with Smith & Nephew (S&N) about a potential £15bn merger…....
...Analysts estimate that S&N has around 12 per cent of the global hip and knee reconstruction market....
...However, with Biomet also reporting net debt equivalent to 5.7 times operating earnings, the US group looked too stretched to afford a conventional bid, analysts said....
...And if there’s anything else you’d like us to explore while we’re on the subject, please let us know in the comments and we’ll do what we can....
...The sale – which excludes US investors owing to regulatory restrictions – will be watched to gauge investor interest in the products....
...The Reconstruction of American Journalism, a report published this week by Leonard Downie, a former Washington Post editor, and Michael Schudson, a Columbia journalism professor, came at an opportune time...
...Last year, S&N was frustrated in its bid to buy Biomet, a US rival, by a group of private equity companies. Since then, it has been seen as a possible future bid target....
...Last December S&N tried to acquire US rival Biomet, but was outbid by a private equity consortium which included included Blackstone, Goldman Sachs, KKR and Texas Pacific, along with one of Biomet’s founders...
...Smith & Nephew has confirmed Salamander Davoudi’s scoop that the company is in talks to merge with Biomet of the US....
...This has been particularly notable in the collapse of the subprime mortgage market in the US, which this year triggered HSBC’s first profit warning....
...Tomkins, on the other hand, looks dreadful as the slowdown among US carmakers continues to hurt....
...Biomet fell 1 per cent to $41.59 after the maker of hip and knee replacement parts accepted a $10.9bn private buy-out offer....
...Smith & Nephew on Thursday confirmed a Financial Times report that it is in preliminary merger discussions with Biomet, its US rival best known for its artificial hips and other replacement joints, in a...
...Good then, to see Smith & Nephew, the British healthcare group, mulling a bid for Biomet, its US rival – even if it is proceeding with the prudence of a geriatric with gammy knees negotiating a spiral staircase...
...Investors were watching whether Smith & Nephew, of the UK, would make a bid for US rival BioMet for up to $12bn. Shares in BioMet rose 4.1 per cent to $41.54....
...US$1bn....
International Edition